SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950137-04-003340
Filing Date
2004-04-29
Accepted
2004-04-29 15:59:34
Documents
3
Period of Report
2004-06-22
Effectiveness Date
2004-04-29

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT c84915ddef14a.htm DEF 14A 243926
2 GRAPHIC c84915dc8491500.gif GRAPHIC 6837
3 GRAPHIC c84915dc8491501.gif GRAPHIC 11189
  Complete submission text file 0000950137-04-003340.txt   263820
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 04764990
SIC: 2836 Biological Products, (No Diagnostic Substances)